Cathie Wood’s ARK ETF adjusts portfolio with GITLAB and ROBINHOOD stock trades

Published 03/04/2025, 01:06
© Reuters

Cathie Wood’s ARK ETFs have published their daily trades for Wednesday, April 2nd, 2025, with a mix of buys and sells that continue to shape their innovative investment strategies. The most significant dollar-value trade of the day saw ARK’s ARKK ETF acquiring 6875 shares of Robinhood Markets Inc (NASDAQ:HOOD) for a total value of approximately $289,849. This purchase suggests a growing confidence in the online brokerage platform, following a similar but larger acquisition of HOOD shares the previous week.

In another notable transaction, ARK bolstered its position in GitLab Inc (NASDAQ:GTLB), buying 2075 shares through ARKK and 614 shares through ARKW, amounting to a total investment of $128,130. This move extends a trend of consistent accumulation of GTLB stock, as seen in the substantial purchases made in the prior days, indicating a strategic emphasis on the software development platform.

On the sell side, ARK divested from two biotech companies. The ARKK ETF sold 19903 shares of Prime Medicine Inc (NASDAQ:PRME) for $35,526, and the ARKG ETF offloaded 73541 shares of Repare Therapeutics Inc (NASDAQ:RPTX) totaling $75,011. These sales contribute to a pattern of reducing exposure in the biotech sector, as evidenced by the sales of PRME and RPTX shares in recent days.

Investors following ARK’s trading activity may find these transactions insightful, as they reflect the fund’s ongoing adjustments to its investment thesis. While the focus on GitLab and Robinhood suggests a bullish stance on technology and fintech, the sales in biotech hint at a more cautious approach to this volatile sector.

As the market continues to evolve, Cathie Wood’s ARK ETFs remain a closely watched barometer for innovation-focused investing, with their daily trades offering a transparent look into the decisions driving their performance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.